Literature DB >> 9828989

Population-based study of the prevalence and presentation of dementia in adults with Down's syndrome.

A J Holland1, J Hon, F A Huppert, F Stevens, P Watson.   

Abstract

BACKGROUND: The reported prevalence rates of dementia in people with Down's syndrome have varied considerably across studies. The aim of this study was to investigate the extent of clinical change with age using an established diagnostic instrument in an unbiased, population-based sample of older people with Down's syndrome.
METHOD: Changes in memory, personality, general mental functioning and daily living skills were assessed using a modified version of the informant interview of the Cambridge Examination for Mental Disorders of the Elderly (CAMDEX).
RESULTS: Age-specific prevalence rates of dementia varied according to the diagnostic criteria used. Using CAMDEX criteria for Alzheimer's disease, prevalence rates increased from 3.4 to 10.3 to 40% in the 30-39, 40-49 and 50-59 age group, respectively.
CONCLUSIONS: Overall, the age-related pattern of presentation and dementia diagnoses differs from that seen in the general elderly population. However, age-specific prevalence rates of Alzheimer's disease were similar but 30-40 years earlier in life.

Entities:  

Mesh:

Year:  1998        PMID: 9828989     DOI: 10.1192/bjp.172.6.493

Source DB:  PubMed          Journal:  Br J Psychiatry        ISSN: 0007-1250            Impact factor:   9.319


  42 in total

1.  Dementia diagnostic criteria in Down syndrome.

Authors:  Rory Sheehan; Amanda Sinai; Nick Bass; Pippa Blatchford; Ingrid Bohnen; Simon Bonell; Ken Courtenay; Angela Hassiotis; Therese Markar; Jane McCarthy; Kamalika Mukherji; Asim Naeem; Dimitrios Paschos; Natalia Perez-Achiaga; Vijaya Sharma; David Thomas; Zuzana Walker; Andre Strydom
Journal:  Int J Geriatr Psychiatry       Date:  2014-11-03       Impact factor: 3.485

2.  The Link between Alzheimer's Disease and Down Syndrome. A Historical Perspective.

Authors:  Ahmad Salehi; J Wesson Ashford; Elliott J Mufson
Journal:  Curr Alzheimer Res       Date:  2016       Impact factor: 3.498

3.  The role of overexpressed DYRK1A protein in the early onset of neurofibrillary degeneration in Down syndrome.

Authors:  Jerzy Wegiel; Karol Dowjat; Wojciech Kaczmarski; Izabela Kuchna; Krzysztof Nowicki; Janusz Frackowiak; Bozena Mazur Kolecka; Jarek Wegiel; Wayne P Silverman; Barry Reisberg; Mony Deleon; Thomas Wisniewski; Cheng-Xin Gong; Fei Liu; Tatyana Adayev; Mo-Chou Chen-Hwang; Yu-Wen Hwang
Journal:  Acta Neuropathol       Date:  2008-08-12       Impact factor: 17.088

4.  Vitamin E in aging persons with Down syndrome: A randomized, placebo-controlled clinical trial.

Authors:  Mary Sano; Paul S Aisen; Howard F Andrews; Wei-Yann Tsai; Florence Lai; Arthur J Dalton
Journal:  Neurology       Date:  2016-05-04       Impact factor: 9.910

5.  The population prevalence of Down's syndrome in England and Wales in 2011.

Authors:  Jianhua Wu; Joan K Morris
Journal:  Eur J Hum Genet       Date:  2013-01-16       Impact factor: 4.246

6.  Behavior and adaptive functioning in adolescents with Down syndrome: specifying targets for intervention.

Authors:  Lisa M Jacola; Francis Hickey; Steven R Howe; Anna Esbensen; Paula K Shear
Journal:  J Ment Health Res Intellect Disabil       Date:  2014-10-03

7.  Obstructive sleep apnea in adults with Down syndrome.

Authors:  Maria S Trois; George T Capone; Janita A Lutz; Maria C Melendres; Alan R Schwartz; Nancy A Collop; Carole L Marcus
Journal:  J Clin Sleep Med       Date:  2009-08-15       Impact factor: 4.062

Review 8.  Mechanisms of tau-induced neurodegeneration.

Authors:  Khalid Iqbal; Fei Liu; Cheng-Xin Gong; Alejandra Del C Alonso; Inge Grundke-Iqbal
Journal:  Acta Neuropathol       Date:  2009-01-30       Impact factor: 17.088

9.  [Living situation of mentally disabled people with dementia in institutions for the disabled: results of a questionnaire in Lower Saxony and Bremen].

Authors:  C Wolff; S V Müller
Journal:  Z Gerontol Geriatr       Date:  2014-07       Impact factor: 1.281

10.  Decrease of protein phosphatase 2A and its association with accumulation and hyperphosphorylation of tau in Down syndrome.

Authors:  Zhihou Liang; Fei Liu; Khalid Iqbal; Inge Grundke-Iqbal; Jerzy Wegiel; Cheng-Xin Gong
Journal:  J Alzheimers Dis       Date:  2008-04       Impact factor: 4.472

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.